Episode 11: Atomic Changes: Reshaping our Data Journey in Small Steps

Host Stan Gloss, founder of BioTeam, invites Mike Tarselli, chief scientific officer at TetraScience, to chat about data and how the life sciences industry thinks about our primary product. They discuss the tech sector’s influence on pharma in switching from a project mindset that yields outputs to a product mindset that yields outcomes and why the industry should use traditional supply chain mechanics as the blueprint to generate and package data. Tarselli also advises biotech companies experiencing a data transformation—as opposed to a digital transformation—to start small and resist the urge to make sweeping changes. “If everybody did these little 1% and 5% hacks here and there, you would have a 20x better laboratory in two years. Data transformation initiatives tend to fail when they go too big,” he says. Lastly, Tarselli shares his hopes for a global and highly collaborative environment that fosters data exchange and readiness in the pharmaceutical space. Links from this episode:  Bio-IT World BioTeam TetraScience TetraScience Announces GxP Solution, $500M Investment in Scientific Data Cloud "I, Pencil" Essay by Leonard E. Read Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders.